Medicine guide
Quintanrix
·
- Prescription status not stated
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus influenzae type B conjugate vaccine (absorbed)
- Made by
- GlaxoSmithKline Biologicals S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Quintanrix is indicated for primary immunisation of infants (during the first year of life) against diphtheria, tetanus, pertussis, hepatitis B and invasive disease caused by Haemophilus influenzae type b and for booster immunisation of young children during the second year of life.The use of Quintanrix should be determined on the basis of official recommendations.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | GlaxoSmithKline Biologicals S.A. |
|---|---|
| Active substance | Diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus influenzae type B conjugate vaccine (absorbed) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Classification | J07CA10 · Antibiotics, antivirals and antifungals taken into the body |
| Authorised on | 2005-02-17 |
| Last updated by the regulator | 2008-09-10 |
| EMA product number | EMEA/H/C/000556 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).